John Hancock Life Insurance Fit Review for Type 2 Diabetes

Research Snapshot

Platform-level ranks: Google 1, OpenAI 2, Anthropic 3, Grok 3, Kimi 3, Perplexity 3, DeepSeek 8.

Why John Hancock Qualified for This Study

Questions This Section Answers

• Is John Hancock a good choice for life insurance for Type 2 diabetes?
• Why did John Hancock rank first for life insurance for Type 2 diabetes when its average rank was only 3.29?

John Hancock qualified because it was the only carrier every included platform named when asked which life insurance carriers are worth considering for applicants with Type 2 diabetes. It appeared in 7 of 7 platform responses and finished first in the final ranking despite an average listed rank of 3.29, because it was the only entity named by all seven platforms.

The qualification rests on a product, not a general reputation. John Hancock Aspire is described across platforms as a program specifically designed for people living with Type 1 or Type 2 diabetes, attachable to eligible term or permanent life insurance ^[1]. Independent reviewers reached the same conclusion: MoneyGeek ranks John Hancock among the best life insurance companies for diabetics because Aspire with Vitality provides activity-based rewards and premium credits specifically for Type 1 and Type 2 diabetes ^[6], and RateChaser describes Aspire as a genuine differentiator rather than a marketing line because very few carriers underwrite this population thoughtfully ^[7].

Platform fit ratings were not unanimous. Five platforms — Anthropic, DeepSeek, Google, Grok, and Kimi — rated John Hancock a "strong" fit. OpenAI and Perplexity rated it "good," with OpenAI stating it should be treated as one strong quote to obtain rather than a proven best-price or best-approval option ^[1].

Two qualification notes from the identity audit apply. Official-site retrieval for johnhancock.com failed during this study, so no official page was independently fetched or verified at the writer stage. And the supplied URLs were collected from platform responses and were not independently validated.

The Product, Model, Plan, or Service Most Relevant to Life Insurance for Type 2 Diabetes

Questions This Section Answers

• Which John Hancock plan should a buyer with Type 2 diabetes choose: Aspire term or Aspire permanent?
• Does John Hancock Aspire require a separate diabetes-only policy, or can it attach to standard term life insurance?

The relevant offering is John Hancock Aspire with Vitality PLUS, attached to an eligible John Hancock term or permanent life insurance policy. Aspire is not a standalone diabetes policy; it is a program layered onto conventional coverage.

Platforms described the structure consistently. Aspire is available with any John Hancock term or permanent life insurance policy, allowing applicants to pick the policy that fits their financial goals ^[8]. Term options include 10-, 15-, 20-, and 30-year periods, with the 30-year option unavailable in New York ^[10]. Permanent categories referenced across platforms include whole life, universal life, and variable universal life ^[11], though Anthropic reported that John Hancock does not offer whole life ^[13] — a direct conflict that buyers should resolve with the carrier.

Vitality PLUS is the paid tier that carries the premium-savings feature. Vitality GO is described as available at no additional cost on eligible products, subject to product and state availability, and premium savings are available only with Vitality PLUS, not Vitality GO ^[14].

For a buyer who wants the lowest-friction path, the practical choice is Aspire attached to a level term policy sized to the coverage need. For a buyer who wants lifetime coverage and cash value, the permanent route exists but adds cost and complexity.

What the AI Platforms Agreed About

Questions This Section Answers

• What do AI platforms agree John Hancock Aspire offers for Type 2 diabetes applicants?
• Is John Hancock Aspire actually designed for Type 2 diabetes, or is it general life insurance with a wellness add-on?

Agreement was strong on four points.

Aspire is diabetes-specific. Every platform described Aspire as a program built for people with Type 1 or Type 2 diabetes rather than a general policy with a marketing label ^[16].

Underwriting considers diabetes-specific factors rather than auto-declining. John Hancock states that underwriting reviews medical history including age at diagnosis, A1C levels, smoking status, current treatment or medication, and other factors ^[23]. The company also states that a prior decline elsewhere does not preclude a John Hancock approval ^[25].

Vitality PLUS can reduce premiums by up to 25%. The savings figure appears across platforms and in company materials, described as cumulative over the life of the policy and dependent on underwriting status, issue age, policy type, policy terms, and achieved Vitality Status ^[16].

Vitality PLUS has a stated fee. For term policies with the optional Vitality rider, the stated cost is 3% of annual premium; for single-life permanent products, $2 per month; for survivorship products, $4 per month ^[28].

Independent reviewers corroborated the differentiation. Investopedia and MoneyGeek both treat Aspire as a diabetes-specific program rather than a generic offer ^[32]. Platform agreement here reflects consistent sourcing, not verified product quality.

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• Is John Hancock Aspire available in my state, and which states are actually excluded?
• What is John Hancock's current approval rate for Type 2 diabetes applicants in 2026?

Disagreement and uncertainty clustered in five areas.

State exclusions conflict. OpenAI reported that John Hancock pages state Aspire is unavailable in New York, Idaho, and Puerto Rico ^[34]. Anthropic and DeepSeek reported the same three ^[35]. Google reported four exclusions — New York, Washington, Idaho, and Puerto Rico ^[37]. Kimi noted conflicting availability reports and added that Vitality GO is unavailable in New York and Puerto Rico ^[39]. The buyer's state-specific eligibility must be verified directly.

Approval-rate data is stale. The 88% approval figure for Type 2 diabetes applicants and 75% for those with related conditions comes from 2018 company material ^[40]. Anthropic explicitly flagged that this data is six to eight years old and that current 2026 approval rates are not publicly available ^[43]. No platform supplied a current figure.

Onduo eligibility thresholds are inconsistently described. Anthropic reported that term policies require at least $500,000 in coverage and permanent policies at least $250,000 for Onduo access, with continued company payment after year one requiring $2M+ term coverage and 900+ annual engagement points ^[44]. Other platforms described Onduo access for "qualifying" Type 2 members without publishing thresholds ^[46]. Google noted that the exact criteria Onduo uses in year two and beyond remain loosely defined ^[37].

Pricing competitiveness is contested. Anthropic reported that at $100,000–$250,000 coverage levels John Hancock rates 16–40% below the national average, with the advantage disappearing at $500,000 ^[48]. Kimi reported the opposite direction, citing average monthly costs of $66 for women and $82 for men versus $42/$54 for Banner Life and $52/$68 for Nationwide ^[49]. These findings cannot both describe the same comparison, and neither is applicant-specific.

Complaint index and no-exam limits are platform-reported. DeepSeek and Kimi both cited a higher-than-average NAIC complaint index for John Hancock, but neither supplied the absolute score or comparison year ^[36]. Grok reported that diabetics are ineligible for Express Track no-exam coverage ^[50], while Kimi reported no-exam coverage available up to $3 million ^[49]. Buyers should verify both.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• What diabetes-management features does John Hancock Aspire include beyond the life insurance policy itself?
• Does John Hancock Aspire include virtual diabetes coaching and glucose monitoring supplies?

Aspire's features fall into three groups: underwriting treatment, diabetes-management support, and wellness rewards.

Underwriting treatment. John Hancock states that underwriting considers age at diagnosis, A1C levels, smoking, current treatment or medication, and other factors, and that diabetes is not an automatic disqualifier ^[51]. DeepSeek and Kimi reported that Type 2 diabetics aged 50 or older with no complications and no insulin use may qualify for Standard Plus, and those 60 or older may qualify for Preferred ^[54]. Kimi flagged that it is unclear whether these represent guaranteed offers or merely eligibility for consideration ^[56].

Diabetes-management support. Aspire materials describe diabetes-support activities including HbA1C management, healthy food, exercise, and sleep ^[57]. Qualifying Type 2 members may access the Onduo virtual clinic, described as including a blood glucose meter, testing supplies, app-based tracking, certified diabetes educators, and virtual physician consultations ^[58]. Onduo excludes applicants with pregnancy, liver failure, end-stage renal disease stage 4–5, grade C–D congestive heart failure, organ or bone marrow transplant, cystic fibrosis, or active malignancy ^[62].

Wellness rewards. Vitality PLUS includes wearable devices such as Apple Watch and Fitbit, a Headspace meditation subscription, healthy food discounts, gym discounts, travel discounts, and subsidized cancer screening for eligible members ^[63]. Apple Watch participation may require an initial $25 payment plus tax and subsequent payments based on qualifying workout activity ^[64].

Two structural caveats apply. Aspire and Vitality benefits do not coordinate with existing health insurance, health plans, or other wellness programs, and the tax treatment of certain benefit values such as gift cards is uncertain and may be includible in taxable income ^[65]. Rewards require program participation, may vary by state and policy, and are not guaranteed to remain unchanged ^[67].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does John Hancock Aspire cost per month, and what is the Vitality PLUS rider fee?
• What happens to my John Hancock premium if I stop participating in Vitality?

No applicant-specific premium, face amount, underwriting class, or policy illustration was publicly available from the reviewed pages. John Hancock directs applicants to an insurance professional for a quote ^[68]. Online quotes are not available for John Hancock life insurance, which multiple platforms flagged as a transparency limitation ^[69].

The advertised savings figure is conditional. John Hancock advertises potential savings of up to 25% compared with the same John Hancock policy without Vitality PLUS, and the savings depend on underwriting status, issue age, policy type, policy terms, and Vitality Status ^[68]. No platform supplied an average realized savings figure.

Contract terms follow the underlying policy. The policy contract controls premiums, exclusions, limitations, lapse provisions, conversion rights, and discontinuance, and Vitality rewards and program features may change and are not guaranteed to remain unchanged for the life of the policy ^[73]. Term policies can generally be converted to permanent coverage subject to specific policy rules ^[74].

Best Suited For

Questions This Section Answers

• Who is John Hancock Aspire best suited for among adults with Type 2 diabetes?
• Is John Hancock worth it for a Type 2 diabetes applicant who will actively use a wellness program?

John Hancock is best suited for applicants with reasonably controlled Type 2 diabetes who want conventional term or permanent coverage and are willing to participate in a wellness program.

Platforms converged on this profile. OpenAI listed applicants with reasonably controlled Type 2 diabetes who want conventional term or permanent coverage, applicants willing to participate in a wellness program and provide health-related information through Vitality, and applicants who value diabetes-management resources, rewards, and possible premium savings ^[75]. Anthropic added applicants previously denied coverage by other insurers due to diabetes ^[76]. Kimi added applicants aged 50 or older with well-controlled Type 2 diabetes, no insulin use, and no complications who may be considered for Standard Plus or Preferred rates ^[77].

The common thread is engagement. The value proposition depends on the buyer actually using the program, because the savings are earned rather than granted.

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose John Hancock Aspire for life insurance with Type 2 diabetes?
• Is John Hancock a bad choice for a Type 2 diabetes applicant who wants the lowest guaranteed premium?

John Hancock is probably not the best fit for four buyer profiles.

Buyers seeking guaranteed-issue or no-underwriting coverage. Aspire does not eliminate underwriting, and John Hancock does not offer final expense or guaranteed-issue coverage if an applicant is declined ^[78].

Buyers who will not use wellness features or whose main objective is the lowest guaranteed premium. OpenAI listed both profiles as poor fits ^[78], and Perplexity listed buyers seeking the cheapest possible policy without wellness program requirements ^[80].

Buyers in a state or product category where Aspire, Vitality PLUS, or specific riders are unavailable. The exact excluded states are disputed across platforms, so this must be verified rather than assumed ^[81].

Buyers with complex diabetes complications who need broad comparison shopping. OpenAI specifically recommended an independent impaired-risk broker for applicants with elevated A1C, insulin use, diabetes complications, recent diagnosis, or prior declines ^[78].

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to John Hancock for a Type 2 diabetes buyer who wants the lowest base premium?
• Which carriers should a Type 2 diabetes applicant compare against John Hancock Aspire?

Several platforms named specific alternatives, and buyers should treat these as comparison candidates rather than verified superior options.

DeepSeek reported that Banner Life offers aggressive rates for A1C under 7.0 for applicants under 60, Protective Life has moderate A1C tolerance, and Symetra is generous for ages 45–70 ^[84]. These are third-party characterizations with partial support strength, not verified rate quotes.

The most reliable path for a buyer with complications, insulin dependence, less-stable A1C, or a prior decline is simultaneous comparison across multiple insurers through an independent impaired-risk broker ^[85].

Questions to Verify Before Buying

Questions This Section Answers

• What should a buyer confirm with John Hancock before signing an Aspire policy?
• How do I verify my John Hancock Aspire underwriting class and total cost before committing?

The following questions come from the platform research and should be answered in writing before a policy is signed.

1. Is Aspire and Vitality PLUS available in my state and with the exact policy type, face amount, and term or permanent product proposed? ^[86]
2. How will my A1C history, age at diagnosis, medications or insulin use, weight, complications, kidney or cardiovascular history, and medical follow-up affect underwriting? ^[86]
3. What underwriting class, premium, exclusions, riders, and contestability terms are being offered in the formal illustration? ^[86]
4. What is the exact Vitality PLUS fee for this policy, and is it included in the quoted premium or charged separately? ^[86]
5. How is the advertised premium savings calculated, what Vitality Status is required, and can the premium increase if participation declines? ^[86]
6. What happens to the base policy, premium, rewards, and any device obligations if I cancel Vitality PLUS? ^[86]
7. For term coverage, what are the conversion rights, conversion deadline, renewal premiums, and post-level-term costs? ^[86]
8. For permanent coverage, what are the guaranteed premiums, cash-value assumptions, surrender charges, loan provisions, and lapse risks? ^[86]
9. If I choose term coverage under $500,000, will I be ineligible for Onduo in year two and beyond, and what are my alternatives for diabetes management support? ^[87]
10. What specific engagement metrics constitute active use of Onduo, and how do I track progress toward maintaining free membership in year two and beyond? ^[87]
11. How do Vitality PLUS wellness rewards trigger tax liability, and what is my estimated tax burden? ^[87]
12. What is the current approval rate for Type 2 diabetes applicants, and how does it vary by age, A1C range, and complication status? ^[87]

Final AI Consensus Verdict

John Hancock is a good fit, with meaningful qualification, for an adult with reasonably stable Type 2 diabetes. It was named by all seven included platforms in the ranking stage and finished first overall, and its Aspire program with Vitality PLUS is the only offering in this study explicitly designed for people with Type 1 or Type 2 diabetes.

The strongest reason to consider it is the combination of diabetes-specific underwriting treatment and a wellness program that can reduce premiums by up to 25% for engaged participants. The main limitation is that no public source establishes applicant-specific pricing, underwriting class, or approval outcome, and the most-cited approval-rate data is from 2018.

Platform agreement here reflects consistent sourcing across seven AI systems, not verified product quality. Buyers should treat John Hancock as one strong quote to obtain and should compare it against at least one alternative carrier, particularly if they have complications, insulin dependence, less-stable A1C results, a prior decline, or limited interest in wellness-program participation.

How This Review Was Produced

This review was produced from a structured multi-platform research run dated 2026-09-22. Seven AI platforms — Anthropic, DeepSeek, Google, Grok, Kimi, OpenAI, and Perplexity — were asked which life insurance carriers are generally worth considering for an adult with Type 2 diabetes in reasonably stable health. John Hancock was named by all seven and finished first in the final ranking.

Each platform supplied a fit assessment, use-case findings, pricing and terms, limitations, and questions to verify before buying. Those outputs were consolidated into this review. Citations reference the platform and source that supported each claim.

All included platforms evaluated fit, but the platform mention count reflects only platforms that named John Hancock during ranking discovery. Platform-reported research dates are provenance metadata and do not independently prove freshness. Citations are platform-reported evidence, not independently verified facts.

Methodology Limitations

Several limitations apply to this review.

Official-site retrieval for johnhancock.com failed during this study, so no official John Hancock page was independently fetched or verified at the writer stage. The supplied URLs were collected from platform responses and were not independently validated.

The reviewed evidence is primarily John Hancock's own product and marketing material. No independent source reviewed here verifies that John Hancock offers the lowest premiums, the most favorable diabetes underwriting, or superior approval outcomes for this buyer profile ^[88].

Approval-rate data cited across platforms is from 2018 and may not reflect current conditions ^[89]. The up-to-25% savings claim is conditional, cumulative, product-dependent, and tied to Vitality participation, and no average realized savings figure was published ^[88].

State availability is disputed across platforms, with three-state and four-state exclusion lists both appearing in the research. Pricing competitiveness findings point in opposite directions across platforms and cannot both describe the same comparison.

No platform supplied an applicant-specific premium, face amount, underwriting class, or policy illustration. Buyers should verify all cost, eligibility, and availability details directly with the carrier or an independent broker before purchasing.

See the broader Life Insurance for Type 2 Diabetes consensus index for comparisons across qualified options.